La vendita allo scoperto per Plus Therapeutics dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Plus Therapeutics. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Plus Therapeutics (NASDAQ:PSTV) Azioni, Report sulle vendite allo scoperto

Plus Therapeutics

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Plus Therapeutics Inc

POSTAL SVGS CHINA UNS/ADR by Postal Svgs Bk of China Ltd.

Postal Savings Bank Of China Co Ltd

<a href="https://x.com/presssec/status/1914371752685076757?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg">https://x.com/presssec/status/1914371752685076757?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg</a>

News

Politics

General

'White House Says NPR Report On Search For New Defense Secretary Is 'Fake News''

HC Wainwright &amp; Co. analyst Douglas Tsao reiterates Roivant Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROIV#NASDAQ">ROIV</a>) with a Buy and maintains $18 price target.

Price Target

Reiteration

Analyst Ratings

ROIV

HC Wainwright & Co. Reiterates Buy on Roivant Sciences, Maintains $18 Price Target

Macquarie analyst Tim Nollen maintains Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Outperform and raises the price target from $1150 to $1200.

NFLX

Macquarie Maintains Outperform on Netflix, Raises Price Target to $1200

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RKLB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$10.00</td>
<td>$56.0K</td>
<td>341</td>
<td>2.0K</td>
</tr>
<tr>
<td>PBI</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$5.00</td>
<td>$271.5K</td>
<td>3.3K</td>
<td>1.7K</td>
</tr>
<tr>
<td>CAR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$75.00</td>
<td>$50.4K</td>
<td>98</td>
<td>980</td>
</tr>
<tr>
<td>ZIM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$16.66</td>
<td>$42.3K</td>
<td>12.7K</td>
<td>864</td>
</tr>
<tr>
<td>BA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/02/25</td>
<td>$155.00</td>
<td>$57.5K</td>
<td>489</td>
<td>432</td>
</tr>
<tr>
<td>LUV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$32.50</td>
<td>$28.6K</td>
<td>3.6K</td>
<td>32</td>
</tr>
<tr>
<td>CMI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$300.00</td>
<td>$39.3K</td>
<td>32</td>
<td>15</td>
</tr>
<tr>
<td>UAL</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/25/25</td>
<td>$91.00</td>
<td>$26.3K</td>
<td>10</td>
<td>14</td>
</tr>
<tr>
<td>GEV</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$400.00</td>
<td>$101.5K</td>
<td>20</td>
<td>10</td>
</tr>
<tr>
<td>NOC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$535.00</td>
<td>$30.3K</td>
<td>38</td>
<td>5</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For RKLB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>), we notice a put option sweep that happens to be bearish, expiring in 60 day(s) on June 20, 2025. This event was a transfer of 2000 contract(s) at a $10.00 strike. This particular put needed to be split into 44 different trades to become filled. The total cost received by the writing party (or parties) was $56.0K, with a price of $28.0 per contract. There were 341 open contracts at this strike prior to today, and today 2005 contract(s) were bought and sold. 
• Regarding PBI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>), we observe a call option trade with neutral sentiment. It expires in 634 day(s) on January 15, 2027. Parties traded 724 contract(s) at a $5.00 strike. The total cost received by the writing party (or parties) was $271.5K, with a price of $375.0 per contract. There were 3331 open contracts at this strike prior to today, and today 1726 contract(s) were bought and sold. 
• Regarding CAR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>), we observe a put option sweep with bearish sentiment. It expires in 116 day(s) on August 15, 2025. Parties traded 46 contract(s) at a $75.00 strike. This particular put needed to be split into 38 different trades to become filled. The total cost received by the writing party (or parties) was $50.4K, with a price of $1097.0 per contract. There were 98 open contracts at this strike prior to today, and today 980 contract(s) were bought and sold. 
• Regarding ZIM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>), we observe a call option sweep with bullish sentiment. It expires in 270 day(s) on January 16, 2026. Parties traded 368 contract(s) at a $16.66 strike. This particular call needed to be split into 18 different trades to become filled. The total cost received by the writing party (or parties) was $42.3K, with a price of $115.0 per contract. There were 12704 open contracts at this strike prior to today, and today 864 contract(s) were bought and sold. 
• Regarding BA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>), we observe a put option trade with bullish sentiment. It expires in 11 day(s) on May 2, 2025. Parties traded 101 contract(s) at a $155.00 strike. The total cost received by the writing party (or parties) was $57.5K, with a price of $570.0 per contract. There were 489 open contracts at this strike prior to today, and today 432 contract(s) were bought and sold. 
• Regarding LUV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>), we observe a put option sweep with bearish sentiment. It expires in 151 day(s) on September 19, 2025. Parties traded 32 contract(s) at a $32.50 strike. This particular put needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $28.6K, with a price of $895.0 per contract. There were 3694 open contracts at this strike prior to today, and today 32 contract(s) were bought and sold. 
• Regarding CMI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>), we observe a call option trade with bearish sentiment. It expires in 423 day(s) on June 18, 2026. Parties traded 15 contract(s) at a $300.00 strike. The total cost received by the writing party (or parties) was $39.3K, with a price of $2620.0 per contract. There were 32 open contracts at this strike prior to today, and today 15 contract(s) were bought and sold. 
• For UAL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>), we notice a put option trade that happens to be neutral, expiring in 4 day(s) on April 25, 2025. This event was a transfer of 10 contract(s) at a $91.00 strike. The total cost received by the writing party (or parties) was $26.3K, with a price of $2633.0 per contract. There were 10 open contracts at this strike prior to today, and today 14 contract(s) were bought and sold. 
• Regarding GEV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>), we observe a put option trade with bearish sentiment. It expires in 116 day(s) on August 15, 2025. Parties traded 10 contract(s) at a $400.00 strike. The total cost received by the writing party (or parties) was $101.5K, with a price of $10150.0 per contract. There were 20 open contracts at this strike prior to today, and today 10 contract(s) were bought and sold. 
• Regarding NOC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>), we observe a put option trade with bearish sentiment. It expires in 25 day(s) on May 16, 2025. Parties traded 15 contract(s) at a $535.00 strike. The total cost received by the writing party (or parties) was $30.3K, with a price of $2020.0 per contract. There were 38 open contracts at this strike prior to today, and today 5 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

RKLB

10 Industrials Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/25/25</td>
<td>$225.00</td>
<td>$25.9K</td>
<td>6.4K</td>
<td>40.3K</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/02/25</td>
<td>$250.00</td>
<td>$124.6K</td>
<td>15.1K</td>
<td>8.2K</td>
</tr>
<tr>
<td>NIO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$3.00</td>
<td>$174.0K</td>
<td>26.8K</td>
<td>2.0K</td>
</tr>
<tr>
<td>GT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$9.00</td>
<td>$65.0K</td>
<td>4.3K</td>
<td>1.1K</td>
</tr>
<tr>
<td>NCLH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$13.00</td>
<td>$36.7K</td>
<td>1.2K</td>
<td>300</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$65.00</td>
<td>$30.0K</td>
<td>1.6K</td>
<td>208</td>
</tr>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/02/25</td>
<td>$44.00</td>
<td>$39.4K</td>
<td>159</td>
<td>188</td>
</tr>
<tr>
<td>GPC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$110.00</td>
<td>$38.4K</td>
<td>42</td>
<td>51</td>
</tr>
<tr>
<td>RH</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/19/25</td>
<td>$125.00</td>
<td>$67.5K</td>
<td>0</td>
<td>31</td>
</tr>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$105.00</td>
<td>$25.8K</td>
<td>1.6K</td>
<td>20</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we observe a put option sweep with bullish sentiment. It expires in 4 day(s) on April 25, 2025. Parties traded 20 contract(s) at a $225.00 strike. This particular put needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $25.9K, with a price of $1295.0 per contract. There were 6425 open contracts at this strike prior to today, and today 40382 contract(s) were bought and sold. 
• Regarding CVNA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>), we observe a call option trade with bullish sentiment. It expires in 11 day(s) on May 2, 2025. Parties traded 2352 contract(s) at a $250.00 strike. The total cost received by the writing party (or parties) was $124.6K, with a price of $53.0 per contract. There were 15167 open contracts at this strike prior to today, and today 8290 contract(s) were bought and sold. 
• For NIO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>), we notice a put option trade that happens to be bearish, expiring in 634 day(s) on January 15, 2027. This event was a transfer of 2000 contract(s) at a $3.00 strike. The total cost received by the writing party (or parties) was $174.0K, with a price of $87.0 per contract. There were 26827 open contracts at this strike prior to today, and today 2002 contract(s) were bought and sold. 
• For GT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GT#NASDAQ">GT</a>), we notice a put option sweep that happens to be bearish, expiring in 88 day(s) on July 18, 2025. This event was a transfer of 1000 contract(s) at a $9.00 strike. This particular put needed to be split into 42 different trades to become filled. The total cost received by the writing party (or parties) was $65.0K, with a price of $65.0 per contract. There were 4354 open contracts at this strike prior to today, and today 1171 contract(s) were bought and sold. 
• For NCLH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>), we notice a put option trade that happens to be bullish, expiring in 634 day(s) on January 15, 2027. This event was a transfer of 150 contract(s) at a $13.00 strike. The total cost received by the writing party (or parties) was $36.7K, with a price of $245.0 per contract. There were 1263 open contracts at this strike prior to today, and today 300 contract(s) were bought and sold. 
• Regarding NKE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), we observe a put option trade with bullish sentiment. It expires in 333 day(s) on March 20, 2026. Parties traded 21 contract(s) at a $65.00 strike. The total cost received by the writing party (or parties) was $30.0K, with a price of $1430.0 per contract. There were 1671 open contracts at this strike prior to today, and today 208 contract(s) were bought and sold. 
• Regarding CMG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>), we observe a call option sweep with bearish sentiment. It expires in 11 day(s) on May 2, 2025. Parties traded 125 contract(s) at a $44.00 strike. This particular call needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $39.4K, with a price of $318.0 per contract. There were 159 open contracts at this strike prior to today, and today 188 contract(s) were bought and sold. 
• Regarding GPC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>), we observe a put option sweep with bearish sentiment. It expires in 116 day(s) on August 15, 2025. Parties traded 51 contract(s) at a $110.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $38.4K, with a price of $750.0 per contract. There were 42 open contracts at this strike prior to today, and today 51 contract(s) were bought and sold. 
• For RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>), we notice a put option trade that happens to be neutral, expiring in 242 day(s) on December 19, 2025. This event was a transfer of 29 contract(s) at a $125.00 strike. The total cost received by the writing party (or parties) was $67.5K, with a price of $2330.0 per contract. There were 0 open contracts at this strike prior to today, and today 31 contract(s) were bought and sold. 
• For BABA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), we notice a call option trade that happens to be bullish, expiring in 151 day(s) on September 19, 2025. This event was a transfer of 17 contract(s) at a $105.00 strike. The total cost received by the writing party (or parties) was $25.8K, with a price of $1520.0 per contract. There were 1639 open contracts at this strike prior to today, and today 20 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BABA

CVNA

NCLH

TSLA

10 Consumer Discretionary Stocks Whale Activity In Today's Session

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Compass Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPX#NASDAQ">CMPX</a>) with a Buy and maintains $24 price target.

CMPX

HC Wainwright & Co. Reiterates Buy on Compass Therapeutics, Maintains $24 Price Target

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/25/25</td>
<td>$95.00</td>
<td>$25.4K</td>
<td>22.1K</td>
<td>82.7K</td>
</tr>
<tr>
<td>AAPL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/25/25</td>
<td>$190.00</td>
<td>$37.2K</td>
<td>9.0K</td>
<td>26.6K</td>
</tr>
<tr>
<td>MSTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/25/25</td>
<td>$320.00</td>
<td>$44.9K</td>
<td>4.8K</td>
<td>9.0K</td>
</tr>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/02/25</td>
<td>$95.00</td>
<td>$25.2K</td>
<td>2.2K</td>
<td>2.6K</td>
</tr>
<tr>
<td>STX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$60.00</td>
<td>$25.9K</td>
<td>8</td>
<td>860</td>
</tr>
<tr>
<td>OKTA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$87.50</td>
<td>$147.1K</td>
<td>512</td>
<td>815</td>
</tr>
<tr>
<td>TSM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$140.00</td>
<td>$120.8K</td>
<td>7.0K</td>
<td>691</td>
</tr>
<tr>
<td>ZS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$160.00</td>
<td>$184.5K</td>
<td>476</td>
<td>506</td>
</tr>
<tr>
<td>MU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/09/25</td>
<td>$70.00</td>
<td>$92.6K</td>
<td>473</td>
<td>485</td>
</tr>
<tr>
<td>APH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$60.00</td>
<td>$26.0K</td>
<td>2.3K</td>
<td>224</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• For NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we notice a put option sweep that happens to be bullish, expiring in 4 day(s) on April 25, 2025. This event was a transfer of 91 contract(s) at a $95.00 strike. This particular put needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $25.4K, with a price of $280.0 per contract. There were 22167 open contracts at this strike prior to today, and today 82712 contract(s) were bought and sold. 
• For AAPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), we notice a put option trade that happens to be bullish, expiring in 4 day(s) on April 25, 2025. This event was a transfer of 100 contract(s) at a $190.00 strike. The total cost received by the writing party (or parties) was $37.2K, with a price of $372.0 per contract. There were 9015 open contracts at this strike prior to today, and today 26610 contract(s) were bought and sold. 
• For MSTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), we notice a call option sweep that happens to be bullish, expiring in 4 day(s) on April 25, 2025. This event was a transfer of 50 contract(s) at a $320.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $44.9K, with a price of $899.0 per contract. There were 4834 open contracts at this strike prior to today, and today 9096 contract(s) were bought and sold. 
• For PLTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), we notice a call option trade that happens to be neutral, expiring in 11 day(s) on May 2, 2025. This event was a transfer of 80 contract(s) at a $95.00 strike. The total cost received by the writing party (or parties) was $25.2K, with a price of $315.0 per contract. There were 2267 open contracts at this strike prior to today, and today 2653 contract(s) were bought and sold. 
• For STX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>), we notice a call option trade that happens to be bearish, expiring in 151 day(s) on September 19, 2025. This event was a transfer of 15 contract(s) at a $60.00 strike. The total cost received by the writing party (or parties) was $25.9K, with a price of $1730.0 per contract. There were 8 open contracts at this strike prior to today, and today 860 contract(s) were bought and sold. 
• For OKTA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>), we notice a put option sweep that happens to be bearish, expiring in 25 day(s) on May 16, 2025. This event was a transfer of 550 contract(s) at a $87.50 strike. This particular put needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $147.1K, with a price of $268.0 per contract. There were 512 open contracts at this strike prior to today, and today 815 contract(s) were bought and sold. 
• For TSM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>), we notice a put option sweep that happens to be bearish, expiring in 25 day(s) on May 16, 2025. This event was a transfer of 253 contract(s) at a $140.00 strike. This particular put needed to be split into 10 different trades to become filled. The total cost received by the writing party (or parties) was $120.8K, with a price of $478.0 per contract. There were 7008 open contracts at this strike prior to today, and today 691 contract(s) were bought and sold. 
• For ZS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>), we notice a put option sweep that happens to be bearish, expiring in 270 day(s) on January 16, 2026. This event was a transfer of 121 contract(s) at a $160.00 strike. This particular put needed to be split into 36 different trades to become filled. The total cost received by the writing party (or parties) was $184.5K, with a price of $1525.0 per contract. There were 476 open contracts at this strike prior to today, and today 506 contract(s) were bought and sold. 
• Regarding MU (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), we observe a call option sweep with bearish sentiment. It expires in 18 day(s) on May 9, 2025. Parties traded 378 contract(s) at a $70.00 strike. This particular call needed to be split into 11 different trades to become filled. The total cost received by the writing party (or parties) was $92.6K, with a price of $245.0 per contract. There were 473 open contracts at this strike prior to today, and today 485 contract(s) were bought and sold. 
• Regarding APH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>), we observe a put option sweep with bearish sentiment. It expires in 25 day(s) on May 16, 2025. Parties traded 110 contract(s) at a $60.00 strike. This particular put needed to be split into 29 different trades to become filled. The total cost received by the writing party (or parties) was $26.0K, with a price of $235.0 per contract. There were 2365 open contracts at this strike prior to today, and today 224 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

MSTR

NVDA

OKTA

PLTR

10 Information Technology Stocks With Whale Alerts In Today's Session

Stephens &amp; Co. analyst Jim Salera reiterates Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) with a Equal-Weight and maintains $54 price target.

Stephens & Co. Reiterates Equal-Weight on Chipotle Mexican Grill, Maintains $54 Price Target

JP Morgan analyst Jessica Fye maintains United Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTHR#NASDAQ">UTHR</a>) with a Overweight and lowers the price target from $357 to $355.

UTHR

JP Morgan Maintains Overweight on United Therapeutics, Lowers Price Target to $355

JP Morgan analyst Anthony Elian maintains Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) with a Underweight and lowers the price target from $78 to $70.

TCBI

JP Morgan Maintains Underweight on Texas Capital Bancshares, Lowers Price Target to $70

<a href="https://www.npr.org/2025/04/21/nx-s1-5371312/trump-white-house-pete-hegseth-defense-department">https://www.npr.org/2025/04/21/nx-s1-5371312/trump-white-house-pete-hegseth-defense-department</a>

'The White House Has Begun Process Of Looking For New Secretary Of Defense'- NPR

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Cytokinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) with a Buy and maintains $120 price target.

CYTK

HC Wainwright & Co. Reiterates Buy on Cytokinetics, Maintains $120 Price Target

JP Morgan analyst DS Kim maintains TAL Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAL#NYSE">TAL</a>) with a Overweight and lowers the price target from $17 to $16.

JP Morgan Maintains Overweight on TAL Education, Lowers Price Target to $16

JP Morgan analyst Anthony Elian maintains Synovus Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNV#NYSE">SNV</a>) with a Overweight and lowers the price target from $54 to $50.

JP Morgan Maintains Overweight on Synovus Financial, Lowers Price Target to $50

JP Morgan analyst Casey Woodring maintains QuidelOrtho (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QDEL#NASDAQ">QDEL</a>) with a Underweight and lowers the price target from $38 to $25.

QDEL

JP Morgan Maintains Underweight on QuidelOrtho, Lowers Price Target to $25

RBC Capital analyst Andrew Wong maintains Aclara Resources (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ARA#TSX">ARA</a>) with a Sector Perform and raises the price target from C$0.7 to C$0.85.

TSX:ARA

RBC Capital Maintains Sector Perform on Aclara Resources, Raises Price Target to C$0.85

JP Morgan analyst DS Kim maintains New Oriental Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) with a Neutral and lowers the price target from $50 to $48.

New Oriental Education & Technology Group

JP Morgan Maintains Neutral on New Oriental Education, Lowers Price Target to $48

Food safety company Neogen Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOG#NASDAQ">NEOG</a>) on Monday agreed to sell its global cleaners and disinfectants business to Kersia Group.
Kersia offers biosecurity, disinfection <a href="https://www.benzinga.com/pressreleases/25/04/b44896153/neogen-announces-sale-of-cleaners-disinfectants-business" target="_blank" rel="noreferrer noopener">and hygiene solutions</a>.
Deal consideration consists of $130 million in cash at closing plus contingent consideration tied to the future performance of the business.
Neogen says the transaction is expected to be accretive to margins and close in the first quarter of the company&#8217;s 2026 fiscal year.
The net proceeds will be used to fully repay the $100 million drawn on the company&#8217;s revolving credit facility in the recent term loan refinancing, with the divestiture expected to reduce the company&#8217;s net leverage ratio by approximately 0.4x on a pro forma basis.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/health-care/25/04/44709995/neogen-q3-earnings-fall-short-on-expectations-cuts-guidance-amid-macro-headwinds-and-tariff-concerns" rel="noreferrer noopener">Neogen Q3 Earnings Fall Short On Expectations, Cuts Guidance Amid Macro Headwinds And Tariff Concerns</a>
&#8220;The sale of our cleaners and disinfectants business further focuses Neogen on food safety diagnostics and continuing to build on our leadership position in what we believe is an attractive end market with long-term tailwinds,&#8221; said John Adent, president and CEO of Neogen. 
&#8220;The cleaners and disinfectants business has been a strong contributor to our Animal Safety segment and Neogen is committed to a smooth transition for customers, employees and other stakeholders. We expect Kersia&#8217;s prioritization of investment and growth in the biosecurity market will benefit the business and provide sharpened strategic focus to maximize its potential for continued growth.&#8221;
With approximately $60 million in annual revenue, Neogen&#8217;s cleaners and disinfectants are used in a range of livestock applications, including swine, poultry, and ruminant operations.
Earlier this month, Neogen refinanced the remaining $550 million principal of its original $650 million term loan, as well as its revolving credit facility, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44665667/neogen-announces-refinancing-of-term-loan-and-revolving-credit-facility" rel="noreferrer noopener">due in August 2027</a>.
The new $450 million term loan and $250 million revolving credit facility mature in April 2030, extending the previous maturity by over two and a half years.
With an upsizing of the company&#8217;s revolving credit facility from $150 million to $250 million and an initial draw of $100 million, the refinancing represents a leverage-neutral transaction.
&#8220;We are pleased to complete this refinancing, which not only maintains our current liquidity position and extends the maturity of the term loan and revolving credit facility, but also results in a lower interest rate,&#8221; said David Naemura, CFO and COO of Neogen.
NEOG Price Action: Neogen stock is up 4.90% at $4.61 at publication on Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/04/44894989/astrazeneca-daiichi-sankyos-multi-billion-dollar-cancer-drug-shows-superior-efficacy-across-broad-her2-positive-metastatic-breast-cancer-patients" target="_blank" rel="noreferrer noopener">AstraZeneca- Daiichi Sankyo&#8217;s Multi-Billion Dollar Cancer Drug Shows Superior Efficacy Across Broad HER2 Positive Metastatic Breast Cancer Patients</a></li>
</ul>
Photo: Shutterstock

Health Care

NEOG

Neogen Seeks To Cut Debt, Streamline Focus With Sale Of Cleaners, Disinfectants Business For $130 Million

WIIM

UBER

Uber shares are trading lower after the FTC filed a lawsuit against the company.

JP Morgan analyst Andrew Steinerman maintains ManpowerGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAN#NYSE">MAN</a>) with a Neutral and lowers the price target from $65 to $50.

JP Morgan Maintains Neutral on ManpowerGroup, Lowers Price Target to $50

Financing

Press Releases

Plus Therapeutics Secures Private Placement of Approximately $15 Million in Gross Proceeds

Plus Therapeutics Announces New Employment Inducement Grants

Plus Therapeutics Granted U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda for the Treatment of Leptomeningeal Metastases in Patients with Lung Cancer

Plus Therapeutics Announces Peer-Reviewed Publication in Nature Communications Highlighting Promising Phase 1 Results for Rhenium (186Re) Obisbemeda in Glioblastoma

Plus Therapeutics Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement

Offerings

D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq:PSTV) in Connection with its up to $15.0 Million Private Placement

Plus Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 27, 2025

Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate

Earnings

Plus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Plus Therapeutics Presents New Data Highlighting Clinical Benefit and Safety of REYOBIQ in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases

PSTV

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

Alzamend Neuro

180 Life Sciences

Azitra

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Galecto

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Mustang Bio

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

Oragenics

Organovo Holdings

Palisade Bio

Sunshine Biopharma

SILO Pharma

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Spruce Biosciences

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Theriva Biologics

Longevity Health Holdings, Inc. - Common Stock

Comments

Plus Therapeutics

Vendite allo scoperto

Plus Therapeutics (NASDAQ:PSTV) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO